Hypothesis

Age‑related decline in colonocyte mitochondrial respiration reduces intracellular oxygen consumption, raising luminal O₂ levels and shifting the redox balance toward an environment that disfavors obligate anaerobic butyrate‑producing Firmicutes while favoring facultative anaerobes such as Enterobacteriaceae. This metabolic‑oxygen feedback accelerates the observed drop in the Firmicutes/Bacteroidetes (F/B) ratio after age 70 and creates a self‑reinforcing loop that drives inflammaging.

Mechanistic Basis

Butyrate‑producing Firmicutes (e.g., Faecalibacterium prausnitzii, Roseburia spp.) thrive under low‑oxygen, high‑redox‑potential conditions generated by colonocyte β‑oxidation of butyrate, which consumes O₂ and maintains a steep epithelial‑luminal oxygen gradient[2][3]. As colonocytes age, mitochondrial dysfunction decreases their oxidative capacity[4], lowering O₂ consumption and increasing luminal O₂. Higher O₂ suppresses the growth of strict anaerobes and promotes aerobic or facultative microbes, altering community composition independent of diet or immune changes. Simultaneously, reduced butyrate signaling via FFAR2/3 diminishes mucin production[5], thinning the mucus layer and further increasing O₂ diffusion to the lumen. The resulting microbial shift lowers butyrate synthesis, worsening colonocyte mitochondrial fuel supply—a vicious cycle.

Testable Predictions

1. Luminal O₂ measurements in colonic contents of young (3‑month), middle‑aged (12‑month), and old (24‑month) mice will show a stepwise increase with age, correlating inversely with fecal butyrate concentration and the F/B ratio[1].
2. Pharmacological boosting of colonocyte mitochondrial respiration (e.g., with SS‑31 elamipretide) in aged mice will reduce luminal O₂, restore butyrate‑producing Firmicutes, and improve barrier function even without exogenous butyrate.
3. Genetic ablation of FFAR2 in colonocytes will exacerbate the age‑related O₂ rise and accelerate loss of butyrate producers, whereas overexpression will blunt the O₂ increase.
4. Human correlative study: colonic biopsies from donors >70 yr will exhibit lower mitochondrial respiratory capacity (measured by high‑resolution respirometry) and higher luminal O₂ (via microelectrode) compared with donors 30‑50 yr, with both parameters predicting fecal butyrate levels and F/B ratio.

Potential Experiments

• Use Seahorse XF analysis on isolated colonocytes from age‑stratified mice to quantify basal and maximal OCR.
• Measure luminal O₂ with Clark‑type microelectrodes inserted into the colon lumen of live animals under anesthesia.
• Perform 16S rRNA sequencing and quantitative PCR for butyrate‑kinase genes alongside O₂ and butyrate assays.
• Treat aged mice with SS‑31 (1 mg/kg/day, i.p.) for 4 weeks; assess mucin thickness (Pas staining), FITC‑dextran permeability, and inflammatory cytokines.
• In FFAR2‑fl/fl; Villin‑Cre mice, repeat aging protocol and compare outcomes to wild‑type littermates.
• For human validation, obtain colonic mucosa from screening colonoscopies, isolate crypts, run mitochondrial respiration assays, and simultaneously sample luminal gas for O₂ using flexible catheter‑based sensors.

If luminal O₂ rises with colonocyte mitochondrial decline and precedes loss of butyrate producers, the hypothesis is supported; if O₂ remains unchanged or butyrate producers decline despite normal mitochondrial function, the hypothesis is falsified.